We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
Trial record 50 of 168 for:    gum disease | Recruiting Studies

Pulpotomy vs Pulpectomy Outcome. (PULPSAVE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02727088
Recruitment Status : Recruiting
First Posted : April 4, 2016
Last Update Posted : November 11, 2016
Rennes University Hospital
Nantes University Hospital
University Hospital, Clermont-Ferrand
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris

Brief Summary:

Epidemiological data show a significant rate of failure of endodontic treatment of 20 to 50% worldwide, probably directly related to the difficulty of the procedure. A successful pulpotomy allows the preservation of a vital radicular pulp into the root canal. The presence of a biological tissue into the root canal is definitely more efficient than a "complete" filling with an inert material. It has been shown on animal and human studies that this pulp stump in contact with the biomaterial is able to regenerate a dentinal plug, with the same architecture as physiologic dentin.

Primary objective : To compare the success rates of root canal treatment (reference) and conservative treatment (pulpotomy) for treating inflamed dental pulp on permanent mature teeth.

Secondary objectives : (1) To describe the clinical and biological prognostic factors of these two treatments; (2) to assess the additional value of biomarkers expression levels as a prognostic tool for clinical decision making (radical vs. conservative treatment); (3) to assess the impact of treatment on post-procedural pain.

This trial aims to demonstrate the non-inferiority of conservative pulpal treatment over endodontic treatment.

Patients consulting in one of the seven study centers, presenting one of the indications retained for the trial and giving written informed consent will receive the treatment (endodontic treatment or conservative treatment) allocated by randomization (stratified over the clinical diagnosis of the pulp status).

The follow up of patients include, a phone call at D15, and visit at 1, 6, 12 and 14 post operative months. Clinical examination and Xrays at 6, 12 and 24 months) will be used to evaluate the success or failure of the treatment.

During the treatment, a sample of pulp tissue will be withdrawn and transferred to a molecular biology laboratory for analysis of inflammation biomarkers. The aim of this part of the sudy is to assess a putative relationship (1) of regulation of biomarkers expression and clinical diagnosis, and (2) of regulation of these biomarkers and success rate of pulpotomy.

Success/failure evaluation:

The primary endpoint is the time to necessity of endodontic reintervention (analysed as a time to failure). This study will use an Intention To Treat analysis as its main assessment ; a secondary assessment accounting for peroperative conversions will assess the practical impact of these conversions. We will distinguish

  • Direct failure (means that the failure is directly correlated to the treatment) : the reintervention need is due to the evolution of the treated tooth. This includes delayed onset of desmodontitis, periodontal space enlargement and/or periapical/periradicular radiolucency (PAI>2) demonstrating an infection of the root canal system (filled by either pulpal stump or filling material).
  • Indirect failure (means that the cause of the failure is not directly related to the endodontic treatment choice) : any event leading to endodontic reintervention indication NOT caused by radicular infection or restoration failure attributable to inadequate restoration. For example : new need of post-placement for treatment of loss of another tooth, unexpected progression of periodontal disease.

Both these failure modes are of interest for analysis : the direct failure time is an indication if the intrinsic value of a therapy, whereas the gross (direct+indirect) failure time is an indication of its clinical relevance (a good therapy applicable in rare cases may be less interesting than a mediocre but widely applicable one).

Statistical analysis:

The classical methods of descriptive analysis will be used to describe the raw results.

In order to make inferences directly on possible clinical results, this study will be analyzed in a Bayesian framework.

This study has been designed in reference with a frequentist demonstration of non-inferiority.

A non-inferiority trial with first and second species error rates α and β has the same operational characteristics as a superiority (unilateral trial) of error rates alpha and beta, which in turn needs the same study size as a comparison (=bilateral) trial with error rates α and 2β.

The final planned size of the trial is established as follows :

  • Ideal plan : a nonparametric comparison (logrank test) fulfilling these goals according to this plan needs 158 patients overall under "perfect information" assumptions (no loss to follow-up, single analysis)
  • Loss to follow-up : the expected loss to follow-up will cause about 22% of included patients to drop out of the study before final analysis this leads to include 194 patients overall.

Sequential analysis : since we wish to be able to follow the progress of the study, and to interrupt it if the main goal is reached, we choose to use a sequential analysis. A Pocock scheme needs to increase the sample size by 16% , leading to plan to recruit 226 patients overall.

Condition or disease Intervention/treatment
Inflammatory Pulp Diseases Related to Carious Teeth Procedure: Pulpotomy Procedure: Pulpectomy

  Show Detailed Description

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 226 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Comparative Randomized Clinical Comparison of Pulp Chamber Pulpotomy and Root Canal Treatment (Pulpectomy) as a Permanent Endodontic Treatment of Mature Permanent Teeth: Analysis of Relationship Between Inflammation Biomarkers Pulpal Expression and Treatment Outcome
Study Start Date : September 2016
Estimated Primary Completion Date : September 2019
Estimated Study Completion Date : September 2020

Arm Intervention/treatment
Active Comparator: Pulpectomy : root canal treatment
Pulpectomy : ablation of the whole dental pulp, preparation and filling of the whole root canal system
Procedure: Pulpectomy
ablation of the whole dental pulp, preparation and filling of the whole root canal system
Other Name: root canal treatment (reference treatment)
Experimental: Pulpotomy : Conservative pulp management
Pulpotomy : ablation of the coronal part of the pulp
Procedure: Pulpotomy
Conservative pulp management (experimental treatment): ablation of the coronal part of the pulp

Primary Outcome Measures :
  1. To compare the success rates of root canal treatment (pulpectomy, reference) and conservative treatment (pulpotomy) [ Time Frame: up to M36 ]
    Time to treatment failure, as assessed by the existence of an indication of re-intervention (with or without contra-indication).

Secondary Outcome Measures :
  1. To assess the impact of treatment on post-procedural pain [ Time Frame: D7 ]
    Acute post-operative pain

  2. To describe the clinical prognostic factors of these two treatments [ Time Frame: baseline, M1, M6, M12, M24, M36 and time to re-treatment ]
    Clinical and radiological signs such as pain, maxillary bone lesion, periodontal attachment loss, …

  3. To assess the additional value of biomarkers expression levels as a prognostic tool for clinical decision making (pulpectomy vs. pulpotomy). [ Time Frame: baseline ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria :

  1. Adult patients ( ≥ 18 years old),
  2. Signed a written informed consent,
  3. Mature permanent teeth, presenting with either:

    1. any indication of pulpectomy on asymptomatic pulp,
    2. pulp exposure during treatment of deep caries,
    3. reversible and irreversible pulpitis.
  4. Access to permanent restorative treatment in a reasonable delay (1 month) after treatment.
  5. Patient has a health coverage (affiliation to social security system or similar, excluding AME (Aide Médicale d'Etat)

Non-inclusion criteria :

  1. General:

    1. Patient deprived of liberty or under legal protection measure
    2. Pregnant or nursing (lactating) woman or who does not apply effective contraception during the study
    3. Impossible or dubious follow-up;
    4. Any general contra-indication to endodontic procedures;
    5. Compromised general prognosis;
    6. Immunodeficiency;
    7. Anticoagulant and/or antiplatelet drug therapy
    8. Participation to another clinical trial (to be discussed with the other trial's investigators);
    9. Impossible or dubious post-procedure restorative treatment.
  2. Local (pertaining to the candidate tooth):

    1. Compromised local prognosis (e. g. trauma, periodontal disease);
    2. Treatment plan including avulsion;
    3. Treatment plan including radicular post placement;
    4. Internal or external root resorption;
    5. Preoperative evidence of pulp necrosis;
    6. Presence of pulp stones into the pulp chamber clearly visible on the preoperative radiography.

Extemporaneous exclusion criteria:

  1. Peroperative clinical evidence of complete or partial pulp necrosis (in one root at least on multirooted teeth);
  2. Impossibility to control haemorrhage of the pulp on one canal at least.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02727088

Contact: Stéphane SIMON, DDS, Mphil, PhD 33142161497 stephane.simon@aphp.fr
Contact: Marjorie ZANINI, DDS 33142161014 marjoriezanini@hotmail.fr

Hôpital Pitié Salpêtriere Recruiting
Paris, France, 75651
Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris
Rennes University Hospital
Nantes University Hospital
University Hospital, Clermont-Ferrand
Principal Investigator: Stéphane SIMON, DDS, Mphil, PhD Assistance Publique - Hôpitaux de Paris

Responsible Party: Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier: NCT02727088     History of Changes
Other Study ID Numbers: P140941
IDRCB ( Other Identifier: 2015-A01509-40 )
First Posted: April 4, 2016    Key Record Dates
Last Update Posted: November 11, 2016
Last Verified: September 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Assistance Publique - Hôpitaux de Paris:
Dental Pulp Disease
Pulp Capping

Additional relevant MeSH terms:
Dental Caries
Tooth Demineralization
Tooth Diseases
Stomatognathic Diseases